Delivery Order SPE2DB20D3103-SPE2DB22FM8F1
- Not listed
- This federal contract award is for the delivery of Januvia 100 mg tablets to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $16,324.06, is a delivery order under the company's $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which runs through November 2026. This IDC serves as the primary vehicle for Amerisourcebergen to supply...
- This federal contract award is for the delivery of pharmaceutical products, including the drug Januvia 100 mg tablets, to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through November 2026. This IDC serves as a primary vehicle...
- This federal contract award is for the delivery of Januvia 100 mg tablets in quantities of 1,000 to the Defense Logistics Agency (DLA). The contract, valued at $15,213.42, was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an ultimate completion date of September 1, 2023 and is a firm fixed-price delivery order. There is no set-aside designation mentioned in the information provided. Amerisourcebergen Drug Corp is...
- This federal contract award is for the delivery of Januvia 100 mg tablets to the Defense Logistics Agency (DLA), a defense agency. The contract, valued at $15,796.01, is a delivery order awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is a firm fixed-price arrangement with a period of performance through August 29, 2023. The contract is not designated with a set-aside and was awarded through full and open competition. AmerisourceBergen Drug Corp is a...
- This federal contract award is for the delivery of Januvia 100 mg tablets to the U.S. government. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, worth $20,244.62, is a firm-fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical, a defense agency. The contract has an ultimate completion date of January 12, 2024. Amerisourcebergen Drug Corp is a subsidiary of the parent...
- This federal contract award is for the delivery of pharmaceutical products, specifically Januvia 100 mg tablets, to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a value of $2,786.45 and an ultimate completion date of April 26, 2022. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company,...
- This federal contract award is for the delivery of Januvia 100 mg tablets to the Defense Logistics Agency (DLA), a defense agency. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, and is a Delivery Order under a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC enables the efficient procurement of essential pharmaceutical and medical supplies to support...
- This federal contract award is for the delivery of Januvia 100 mg tablets, a prescription medication, to the Defense Logistics Agency (DLA). The $6,039.99 fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract has an ultimate completion date of April 16, 2024 and is not designated as a set-aside. AmerisourceBergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which maintains a $999,999,999 Indefinite Delivery...
- This federal contract award is for the delivery of Januvia 100 mg tablets to the Defense Logistics Agency (DLA), a defense agency. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, and has a ceiling value of $10,946.57. The contract is a delivery order with a firm fixed price, and the ultimate completion date is December 5, 2024. The contract is not designated with a set-aside requirement, indicating open competition....
- This federal contract award is for the delivery of Januvia 100 mg tablets to the Defense Logistics Agency (DLA), a component of the Department of Defense. The contract, valued at $4,013.67, was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Firm Fixed Price Delivery Order with a period of performance ending on July 6, 2022. The contract does not have a set-aside designation, indicating open competition....
- SPE2DB20D3103Indefinite Delivery Contract
- SPE2DB20D3103-SPE2DB22FM8F1Delivery Order
This federal contract award is for the delivery of Januvia 100 mg tablets to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract award, valued at $5,026.83, is a delivery order under an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, with a total potential value of $999,999,999.00 and running through November 2026. This IDC serves as the primary vehicle for Amerisourcebergen to deliver a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen's parent company, Cencora, Inc., also holds a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at up to $750,000 through May 2024, for similar medical products and prescription drugs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.0k | 3/1/22 |